Javascript must be enabled to continue!
Lectins as Adjuvants and Vaccine Delivery Systems: A Mini-Review
View through CrossRef
Lectins are carbohydrate-binding proteins that have emerged as promising candidates for
vaccine development due to their dual roles as immunomodulatory agents and antigen delivery systems.
Through specific interactions with glycans expressed on immune and epithelial cells, lectins can
enhance antigen uptake, processing, and presentation, modulating innate and adaptive immune responses.
Several lectins have been shown to activate antigen-presenting cells, stimulate cytokine production,
and promote Th1- or Th2-biased immune responses by recognizing glycosylated receptors,
including Toll-like receptors. These properties make lectins attractive alternatives or complements to
conventional vaccine adjuvants. This mini-review summarizes recent advances in the application of
lectins as vaccine adjuvants and delivery platforms. We discuss their mechanisms of action, their contribution
to innate and mucosal immunity, and their ability to target antigens to specialized cells, such
as dendritic cells and intestinal M cells. Special emphasis is placed on mucosal vaccination strategies,
where lectins exhibit unique advantages due to their resistance to gastrointestinal degradation, mucoadhesive
properties, and ability to facilitate transepithelial transport of antigens. We also highlight potential
uses of lectin-functionalized Poly(lactic-co-glycolic acid) (PLGA) nanoparticles, which combine
antigenic protection, targeted delivery, and immunostimulatory activity. In addition, emerging
approaches employing lectin-based surface display systems in microorganisms are discussed as innovative
platforms for antigen presentation and vaccine development. Although several challenges remain
regarding safety, standardization, and clinical translation, the accumulating evidence indicates
that lectins represent versatile tools for increasing vaccine efficacy. A deeper understanding of lectinglycan
interactions may support the development of next-generation vaccines capable of inducing robust,
targeted, and long-lasting protective immune responses.
Title: Lectins as Adjuvants and Vaccine Delivery Systems: A Mini-Review
Description:
Lectins are carbohydrate-binding proteins that have emerged as promising candidates for
vaccine development due to their dual roles as immunomodulatory agents and antigen delivery systems.
Through specific interactions with glycans expressed on immune and epithelial cells, lectins can
enhance antigen uptake, processing, and presentation, modulating innate and adaptive immune responses.
Several lectins have been shown to activate antigen-presenting cells, stimulate cytokine production,
and promote Th1- or Th2-biased immune responses by recognizing glycosylated receptors,
including Toll-like receptors.
These properties make lectins attractive alternatives or complements to
conventional vaccine adjuvants.
This mini-review summarizes recent advances in the application of
lectins as vaccine adjuvants and delivery platforms.
We discuss their mechanisms of action, their contribution
to innate and mucosal immunity, and their ability to target antigens to specialized cells, such
as dendritic cells and intestinal M cells.
Special emphasis is placed on mucosal vaccination strategies,
where lectins exhibit unique advantages due to their resistance to gastrointestinal degradation, mucoadhesive
properties, and ability to facilitate transepithelial transport of antigens.
We also highlight potential
uses of lectin-functionalized Poly(lactic-co-glycolic acid) (PLGA) nanoparticles, which combine
antigenic protection, targeted delivery, and immunostimulatory activity.
In addition, emerging
approaches employing lectin-based surface display systems in microorganisms are discussed as innovative
platforms for antigen presentation and vaccine development.
Although several challenges remain
regarding safety, standardization, and clinical translation, the accumulating evidence indicates
that lectins represent versatile tools for increasing vaccine efficacy.
A deeper understanding of lectinglycan
interactions may support the development of next-generation vaccines capable of inducing robust,
targeted, and long-lasting protective immune responses.
Related Results
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
APPLICATIONS OF PLANT LECTINS IN BIOTECHNOLOGY AND THERAPEUTICS
APPLICATIONS OF PLANT LECTINS IN BIOTECHNOLOGY AND THERAPEUTICS
Lectins are carbohydrate-binding proteins broadly used in various therapeutic and biomedical applications. The variable affinity of lectins towards variety of carbohydrates has rai...
Vaccine candidates, immuno-dominant antigens, and potent vaccine adjuvants for preventing cutaneous leishmaniasis: a sys
Vaccine candidates, immuno-dominant antigens, and potent vaccine adjuvants for preventing cutaneous leishmaniasis: a sys
Background: Cutaneous leishmaniasis (CL) is the most common
clinical form of leishmaniasis that causes skin disease. Currently,
there is no licensed prophylactic vaccine for CL, as...
Plant Phenolics and Lectins as Vaccine Adjuvants
Plant Phenolics and Lectins as Vaccine Adjuvants
Background:
The immune system is responsible for providing protection to the body
against foreign substances. The immune system divides into two types of immune responses to study
...
Lectins and their application to clinical microbiology
Lectins and their application to clinical microbiology
Lectins are generally associated with plant or animal components, selectively bind carbohydrates, and interact with procaryotic and eucaryotic cells. Lectins have various specifici...
PRR adjuvants restrain high stability peptides presentation on APCs
PRR adjuvants restrain high stability peptides presentation on APCs
Abstract
Adjuvants can affect the function of APCs and boost the adaptive immune responses post vaccination. However, whether adjuvants modulate the specificity of ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Measles Vaccination Coverage and Protective Effectiveness in the Amhara Regional State, Ethiopia, 2019-2024
Measles Vaccination Coverage and Protective Effectiveness in the Amhara Regional State, Ethiopia, 2019-2024
Abstract
Background:
Despite the availability of an effective vaccine, measles remains a major public health problem in Ethiopi...

